Perjeta, which is pertuzumab, represents a important advancement in treating HER2-positive breast cancer. It works by blocking a distinct pathway on helps cancer cells grow . Differing from some other HER2-targeted therapies, pertuzumab doesn't directly block the HER2 receptor itself, but instead in